GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Sanofi India Ltd (BOM:500674) » Definitions » E10

Sanofi India (BOM:500674) E10 : ₹260.53 (As of Sep. 2024)


View and export this data going back to 1991. Start your Free Trial

What is Sanofi India E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Sanofi India's adjusted earnings per share data for the three months ended in Sep. 2024 was ₹35.690. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₹260.53 for the trailing ten years ended in Sep. 2024.

During the past 12 months, Sanofi India's average E10 Growth Rate was 4.60% per year. During the past 3 years, the average E10 Growth Rate was 10.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Sanofi India was 10.50% per year. The lowest was 1.40% per year. And the median was 5.95% per year.

As of today (2024-12-14), Sanofi India's current stock price is ₹6205.25. Sanofi India's E10 for the quarter that ended in Sep. 2024 was ₹260.53. Sanofi India's Shiller PE Ratio of today is 23.82.

During the past 13 years, the highest Shiller PE Ratio of Sanofi India was 28.47. The lowest was 12.78. And the median was 18.78.


Sanofi India E10 Historical Data

The historical data trend for Sanofi India's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Sanofi India E10 Chart

Sanofi India Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 222.76 185.66 207.00 232.17 250.64

Sanofi India Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 249.01 250.64 252.99 257.89 260.53

Competitive Comparison of Sanofi India's E10

For the Drug Manufacturers - General subindustry, Sanofi India's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sanofi India's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Sanofi India's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Sanofi India's Shiller PE Ratio falls into.



Sanofi India E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Sanofi India's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=35.69/157.8822*157.8822
=35.690

Current CPI (Sep. 2024) = 157.8822.

Sanofi India Quarterly Data

per share eps CPI Adj_EPS
201412 40.090 96.780 65.401
201503 28.040 97.163 45.563
201506 27.860 99.841 44.056
201509 31.520 101.753 48.907
201512 52.090 102.901 79.922
201603 35.910 102.518 55.303
201606 37.430 105.961 55.771
201609 36.040 105.961 53.700
201612 22.890 105.196 34.354
201703 26.090 105.196 39.157
201706 32.040 107.109 47.228
201709 50.570 109.021 73.234
201712 33.050 109.404 47.695
201803 35.870 109.786 51.584
201806 43.300 111.317 61.413
201809 51.830 115.142 71.069
201812 34.480 115.142 47.279
201903 40.340 118.202 53.882
201906 42.290 120.880 55.235
201909 54.960 123.175 70.446
201912 42.260 126.235 52.854
202003 37.080 124.705 46.945
202006 59.180 127.000 73.570
202009 57.710 130.118 70.024
202012 53.410 130.889 64.425
202103 63.350 131.771 75.903
202106 77.420 134.084 91.161
202109 230.040 135.847 267.354
202112 39.250 138.161 44.853
202203 103.510 138.822 117.722
202206 52.280 142.347 57.985
202209 56.840 144.661 62.035
202212 56.840 145.763 61.566
202303 82.670 146.865 88.872
202306 53.370 150.280 56.070
202309 65.950 151.492 68.732
202312 59.790 152.924 61.728
202403 59.310 153.035 61.189
202406 44.810 155.789 45.412
202409 35.690 157.882 35.690

Add all the adjusted EPS together and divide 10 will get our e10.


Sanofi India  (BOM:500674) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Sanofi India's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=6205.25/260.53
=23.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Sanofi India was 28.47. The lowest was 12.78. And the median was 18.78.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Sanofi India E10 Related Terms

Thank you for viewing the detailed overview of Sanofi India's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Sanofi India Business Description

Traded in Other Exchanges
Address
Saki Vihar Road, Sanofi House, CTS Number 117-B, L&T Business Park, Powai, Mumbai, MH, IND, 400072
Sanofi India Ltd is a drug manufacturing company that focuses on a range of therapeutic areas, including Diabetes, Cardiology, Consumer Healthcare, Hospital, Central Nervous System, and Anti-Histamines. The company's diabetes presence includes oral anti-diabetic products and insulin. The consumer healthcare area also maintains a nutraceutical portfolio. The company's export markets include Germany, the U.K., Australia, and Russia. The company utilizes strategic partnerships as a component of its growth.

Sanofi India Headlines

No Headlines